Vendor Intelligence Report: Dalian Handom Chemicals HDC

Published 3 Jul 2026. 22-page investigative report on who is behind Dalian Handom Chemicals HDC: corporate records, ownership, affiliate networks, and the vendor's lab-testing record. The first 4 pages are free to read on this page.

Researched and published by Finnrick Analytics. Reports draw on corporate records, affiliate-network analysis, and Finnrick's own laboratory testing record; vendors can challenge findings through the formal objections process at finnrick.com/vendor-support/objections.

Executive summary

Across 10 Finnrick lab tests, Dalian Handom Chemicals HDC records 8 pass / 2 fail, an overall pass rate of 80%. The evidence is narrow: only Retatrutide and Tirzepatide are covered, not the wider peptide, API, veterinary-drug, or extract catalog. Retatrutide is the more defensible Handom choice; Tirzepatide is close but weaker because the sample is thinner, a fail is still present, and U.S. import/IP exposure is sharper. Under stricter grading, the apparent cushion narrows.

The corporate trail is active but uneven. Handom presents through two official-looking domains: a peptide-facing site and a legacy bulk-chemical identity now converging toward peptide offerings. The peptide domain is younger than the long-history posture it carries. B2B records add more ambiguity, combining an office-unit address, a 30,000 sqm factory claim, conflicting Manufacturer/Factory and Trading Company labels, and footprint references spanning Dalian, Panjin, Zunyi, and Shenzhen.

Marketing has also moved closer to the end buyer. The active YouTube channel uses dosage-specific weight-loss language for Tirzepatide and Retatrutide, while the primary peptide domain carries a globaleyez IP-rights flag and a very low ScamAdviser trust score. The legacy domain looks cleaner in the same reputation source, creating a split brand-risk picture.

The promotional-network review is calibrated, not sensational. No conventional public coupon/referral program or confirmed copycat domain surfaced. The concern comes from retained Reddit captures showing coordinated-looking praise for Handom and John Wang, low-history defensive accounts, and WhatsApp funneling, without proof of payment or vendor control.

Inside the full report:

  • Complete Finnrick product appendix with pass/fail detail, methodology-divergence charts, and rating trajectories for both tested products
  • Side-by-side domain analysis using dated homepage captures and WHOIS context for handomchemicals.com and handom-chem.com
  • B2B directory comparison of Manufacturer/Factory versus Trading Company claims and Dalian, Panjin, Zunyi, and Shenzhen footprint references
  • Regulatory/IP review covering the globaleyez/ScamAdviser domain split, the USITC tirzepatide record, CBP peptide-seizure context, and ImportYeti/OpenSanctions checks
  • Promotional-footprint review of YouTube Shorts, John Wang X artifacts, Reddit captures, and negative affiliate-sweep results

Risk assessment

  • Product-quality variability risk (Retatrutide and Tirzepatide) — medium: Finnrick record is 10 tests: 8 pass / 2 fail; Retatrutide is 5 pass / 1 fail at 80.65%, and Tirzepatide is 3 pass / 1 fail at 78.57%.
  • GLP-1 import/IP enforcement risk (especially Tirzepatide) — high: Primary peptide domain has a globaleyez IP-rights violation flag and ScamAdviser 16/100; Handom sells Tirzepatide subject to a USITC import-exclusion record for unauthorized U.S. imports.
  • Manufacturing-claim and traceability risk — medium: 30,000 ㎡ factory and large-staff claims are uncorroborated; directories conflict on Manufacturer/Factory vs Trading Company and Dalian/Panjin/Zunyi footprints.
  • Review-manipulation and off-platform promotion risk — medium: Reddit captures show coordinated-looking pro-Handom/John Wang comments and WhatsApp funneling without relationship disclosure; paid control is not proven.
  • Channel-authenticity and brand-confusion risk — medium: Two official-looking domains, dormant/changed social channels, and no surfaced authorized-reseller, official-channel, COA-verification, or anti-counterfeit program.